Billionaire James Dinan’s York Capital Initiated Stakes in These Companies
Though billionaire James Dinan‘s York Capital Management manages regulatory assets worth over $25 billion, its latest 13F filing reveals that less......(read more)
Posts Tagged ‘Medivation Inc. (MDVN)’
Huge Jumps In Hedge Fund Popularity For These 5 Healthcare Stocks
Biotechs have had a very tough year, though the healthcare sector as a whole has managed to rebound into the green year–to-date. While the iShares......(read more)
Why Pfizer, Medivation, GM, and 2 Other Stocks Have Investors Talking
After surging almost non-stop to $49 per barrel from $40, WTI futures are now 2% in the red while the broader indexes are pretty much flat in pre-market......(read more)
5 Merger Arb Plays Added to Havens Advisors’ Portfolio in Q2
No matter how much things have changed over the past several years, Wall Street remains a place that is dominated by men. However, one woman who managed......(read more)
10 Stocks That Had Their Price Targets Raised Tuesday
The markets opened higher today before sliding slightly into the red as investors await June’s data on import and export prices, the Treasury’......(read more)
Monday’s Trending Stocks: CBS, Medivation, HPE, Boeing, Sagent Pharmaceuticals
The benchmark S&P 500 index has jumped six points on Monday, setting a new all-time high as last week’s strong jobs report continues to buoy market......(read more)
Redmile Group Sticking With Healthcare Picks After Rough Q1
Redmile Group is a San Francisco-based, healthcare-focused hedge fund founded and managed by Jeremy Green, an Oxford alum with more than 20 years of experience......(read more)
Why These Five Stocks Are Trending Today?
The US stock market plunged after the bell on the back of April nonfarm payrolls data, which showed that 160,000 jobs were created last month, versus......(read more)
Why Apple (AAPL), Alphabet (GOOG), Pfizer (PFE) and Two Other Stocks are Trending Today
The markets are sliding on Wednesday after a report from Automatic Data Processing, which shows a decline in the growth of private sector employment.......(read more)
Here’s Why Investors Are Watching These Five Stocks Today
It’s the middle of earnings season and many investors are hungrily dissecting earnings reports and management commentary to get a better view on......(read more)
Why Investors Are Buzzing About These Stocks Today
It’s M&A Thursday, as several major M&A deals have been announced today. Among the companies in the mood for mergers and acquisitions are......(read more)
Investors Can’t Get Enough of These 4 Stocks Today
With the S&P 500 and Dow Jones barely in the green as investors remain concerned about China’s slowing economy, Big Lots, Inc. (NYSE:BIG),......(read more)
Mariner Investment Group’s Top Biotech Stock Picks For Q4
Mariner Investment Group is a New York-based investment advisory firm founded by William Michaelcheck in 1992. Apart from its headquarters in New York......(read more)
These Are Apex Capital Management’s Top Biotech Stock Picks
Founded in 1987, Apex Capital Management invests mainly in companies that have market caps of up to $10 billion and is currently overseeing $6.5 billion......(read more)
AstraZeneca plc (ADR) (AZN), Johnson & Johnson (JNJ): Will the Exelixis, Inc. (EXEL) Hype Catch Up to Its Valuation?
The small patient pool for medullary thyroid cancer, or MTC, isn’t going to move the needle for a large pharmaceutical company. But Exelixis, Inc......(read more)
Do Hedge Funds and Insiders Love Seattle Genetics, Inc. (SGEN)?
At the moment, there are a multitude of metrics shareholders can use to monitor stocks. A pair of the most useful are hedge fund and insider trading sentiment......(read more)
Incyte Corporation (INCY): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
Should investors be bullish on Incyte Corporation (NASDAQ:INCY)? In the 21st century investor’s toolkit, there are many gauges shareholders can use......(read more)
This Metric Says You Are Smart to Sell Ariad Pharmaceuticals, Inc. (ARIA)
In the eyes of many investors, hedge funds are seen as overrated, old financial tools of a forgotten age. Although there are over 8,000 hedge funds in......(read more)
Should You Avoid Jazz Pharmaceuticals plc – Ordinary Shares (JAZZ)?
In today’s marketplace, there are a multitude of gauges market participants can use to analyze their holdings. Two of the most innovative are hedge......(read more)
Onyx Pharmaceuticals, Inc. (ONXX) Investors: Listen Up
Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) investors: listen up. In the 21st century investor’s toolkit, there are tons of metrics shareholders can use......(read more)
What Hedge Funds Think About Medivation Inc (MDVN)
Is Medivation Inc (NASDAQ:MDVN) a buy? In today’s marketplace, there are a multitude of methods shareholders can use to monitor the equity markets.......(read more)
Is Illumina, Inc. (ILMN) Going to Burn These Hedge Funds?
If you were to ask many investors, hedge funds are assumed to be useless, old investment tools of a period lost to current times. Although there are more......(read more)
Medivation Inc (MDVN), Seattle Genetics, Inc. (SGEN) – Biotech Buyouts: Who’s Next?
There’s been plenty of buzz lately about the continuing saga of the possible buyout of Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) by Amgen, Inc. (......(read more)
Medivation Inc (MDVN), Dendreon Corporation (DNDN): 3 Positives From Johnson & Johnson (JNJ)’s Latest Acquisition
Johnson & Johnson (NYSE:JNJ) completed its acquisition of privately held Aragon Pharmaceuticals earlier this week. Plans for the deal were first announced......(read more)
Johnson & Johnson (JNJ): Biotechs With Prostate Cancer Treatments
There are many types of biotech companies out there with tremendous value. Today, I will focus on the ones that target prostate cancer. Investors should......(read more)
Medivation Inc (MDVN), Questcor Pharmaceuticals Inc (QCOR): The Best Performing Biotech Stocks of the Last Decade
Biotech is booming these days. But that’s not a new story by any means. Biotech stocks as a group have done very well over the past several years......(read more)
Dendreon Corporation (DNDN): Is Time Running Out for This Fallen Biotech?
There’s a lot to notice from Johnson & Johnson (NYSE:JNJ)’s earnings — the company announced a very solid quarter. But the one thing that......(read more)
Medivation Inc (MDVN), Onyx Pharmaceuticals, Inc. (ONXX): Biotechs Take a Dive After a Standout Start to 2013
Are investors hitting the brakes on biotech? The biotech sector’s one of the most boom-or-bust areas for investors, where fortunes can be won or......(read more)
Hedge Funds Are Buying Incyte Corporation (INCY)
Is Incyte Corporation (NASDAQ:INCY) a buy, sell, or hold? Investors who are in the know are taking an optimistic view. The number of bullish hedge fund......(read more)
Dendreon Corporation (DNDN): This Cancer Drug Developer Could Really Use a Partner
As we’ve learned over the past few years, getting a drug approved by the Food and Drug Administration is just half the battle in the biotech sector......(read more)
UnitedHealth Group Inc. (UNH), Aetna Inc. (AET): The Eight Biggest Health Problems Americans Face
What are the biggest health problems in the U.S.? It depends on whom you ask. The Centers for Disease Control and Prevention would put heart disease at......(read more)
Dendreon Corporation (DNDN) Searching For A Rebound
“We believe that the fourth quarter may be our strongest quarter of the year,” said John Johnson, Dendreon Corporation (NASDAQ:DNDN)‘......(read more)
Dendreon Corporation (DNDN): What You Should Know
Although we don’t believe in timing the market or panicking over market movements, we do like to keep an eye on big changes — just in case......(read more)
Will Dendreon Corporation (DNDN) Ever Make Money?
On Thursday, Dendreon Corporation (NASDAQ:DNDN) will release its latest quarterly results. The key to making smart investment decisions on stocks reporting......(read more)
Avanir Pharmaceuticals, Inc. (AVNR), Medivation Inc (MDVN) & This Week In Biotech
With the SPDR S&P Biotech Index up 31% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......(read more)
Johnson & Johnson (JNJ): This Company’s Biggest Drug Rivals
When it comes to health care companies, there’s no bigger name than the largest firm in the business: Johnson & Johnson (NYSE:JNJ) . What doesn......(read more)
Johnson & Johnson (JNJ), Dendreon Corporation (DNDN): A Magical Drug that Could Change Lives
The biotech sector is perhaps the most volatile and risk-prone sector in the market, but investors still love it. Medical science is leaping forward and......(read more)
What’s Inside Johnson & Johnson (JNJ)’s Pharmaceuticals Business? – Medivation Inc (MDVN), Merck & Co., Inc. (MRK)
When it comes to health care companies, there’s no bigger name than the largest firm in the business: Johnson & Johnson (NYSE:JNJ). What doesn......(read more)
Will Johnson & Johnson (JNJ) Help You Retire Rich?
Now more than ever, a comfortable retirement depends on secure, stable investments. Unfortunately, the right stocks for retirement won’t just fall......(read more)
Johnson & Johnson (JNJ), Dendreon Corporation (DNDN) – Tackling Cancer: Prostate Cancer’s Biggest Current and Upcoming Players
As I commented last week, cancer statistics are both staggering and disappointing. Although cancer deaths per 100,000 people have been on the downswing......(read more)
5 Can’t-Miss Health-Care Events This Week: Zogenix, Inc. (ZGNX), Ariad Pharmaceuticals, Inc. (ARIA)
Normally we have a nice blend of health-care events to take notice of each week. This week I’m steering you squarely toward the biotechnology sector......(read more)
Dendreon Corporation (DNDN) Earnings: An Early Look
Earnings season is now starting to wind down, with most companies already having reported their quarterly results. But there are still some companies......(read more)
Can Johnson & Johnson (JNJ)’s Zytiga Build on a Historic 2012?
Johnson & Johnson (NYSE:JNJ) may offer well-known personal-care products such as Listerine and Neutrogena, but it also boasts an impressive portfolio......(read more)
